AR059621A1 - Acidos 4- fenil- tiazol-5- carboxilicos y amidas de acidos 4- fenil- tiazol5 carboxilicos como inhibidores de la plk1 - Google Patents
Acidos 4- fenil- tiazol-5- carboxilicos y amidas de acidos 4- fenil- tiazol5 carboxilicos como inhibidores de la plk1Info
- Publication number
- AR059621A1 AR059621A1 ARP070100768A ARP070100768A AR059621A1 AR 059621 A1 AR059621 A1 AR 059621A1 AR P070100768 A ARP070100768 A AR P070100768A AR P070100768 A ARP070100768 A AR P070100768A AR 059621 A1 AR059621 A1 AR 059621A1
- Authority
- AR
- Argentina
- Prior art keywords
- group
- lower alkyl
- independently
- hydroxyl
- phenyl
- Prior art date
Links
- 102100031463 Serine/threonine-protein kinase PLK1 Human genes 0.000 title 1
- 239000002253 acid Substances 0.000 title 1
- 150000007513 acids Chemical class 0.000 title 1
- 150000001408 amides Chemical class 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 108010056274 polo-like kinase 1 Proteins 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 7
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 4
- 125000000623 heterocyclic group Chemical group 0.000 abstract 4
- 125000004429 atom Chemical group 0.000 abstract 3
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 239000001257 hydrogen Substances 0.000 abstract 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 2
- 125000003545 alkoxy group Chemical group 0.000 abstract 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 2
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 229910052757 nitrogen Inorganic materials 0.000 abstract 2
- 229910052760 oxygen Inorganic materials 0.000 abstract 2
- 239000001301 oxygen Substances 0.000 abstract 2
- 125000001424 substituent group Chemical group 0.000 abstract 2
- 125000003107 substituted aryl group Chemical group 0.000 abstract 2
- 229910052717 sulfur Inorganic materials 0.000 abstract 2
- 239000011593 sulfur Substances 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 150000002431 hydrogen Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US77696406P | 2006-02-27 | 2006-02-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR059621A1 true AR059621A1 (es) | 2008-04-16 |
Family
ID=38051896
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP070100768A AR059621A1 (es) | 2006-02-27 | 2007-02-23 | Acidos 4- fenil- tiazol-5- carboxilicos y amidas de acidos 4- fenil- tiazol5 carboxilicos como inhibidores de la plk1 |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US7504513B2 (enExample) |
| EP (1) | EP1991543A1 (enExample) |
| JP (1) | JP2009528284A (enExample) |
| KR (1) | KR101060539B1 (enExample) |
| CN (1) | CN101415704A (enExample) |
| AR (1) | AR059621A1 (enExample) |
| AU (1) | AU2007217575A1 (enExample) |
| BR (1) | BRPI0710473A2 (enExample) |
| CA (1) | CA2642921A1 (enExample) |
| CR (1) | CR10206A (enExample) |
| EC (1) | ECSP088700A (enExample) |
| IL (1) | IL193481A0 (enExample) |
| MA (1) | MA30260B1 (enExample) |
| MX (1) | MX2008010884A (enExample) |
| NO (1) | NO20083708L (enExample) |
| RU (1) | RU2008138163A (enExample) |
| TW (1) | TW200745097A (enExample) |
| WO (1) | WO2007096315A1 (enExample) |
| ZA (1) | ZA200807074B (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008149784A1 (ja) * | 2007-06-08 | 2008-12-11 | Nec Corporation | 半導体集積回路及びフィルタ制御方法 |
| WO2009094224A1 (en) | 2008-01-25 | 2009-07-30 | Millennium Pharmaceuticals, Inc. | Thiophenes and their use as phosphatidylinositol 3-kinase (pi3k) inhibitors |
| AU2008354754B2 (en) * | 2008-04-17 | 2014-09-11 | The Johns Hopkins University | On01910. Na enhances chemotherapeutic agent activity in drug-resistant tumors |
| JP2012502404A (ja) * | 2008-09-10 | 2012-01-26 | データレース リミテッド | データ保存媒体 |
| WO2010077295A1 (en) * | 2008-12-09 | 2010-07-08 | King Faisal Specialist Hospital & Research Centre | Substituted tricyclic heterocycles and uses to treat tumors and proliferative disorders |
| JP2012512223A (ja) | 2008-12-18 | 2012-05-31 | エフ．ホフマン−ラ ロシュ アーゲー | チアゾリル−ベンズイミダゾール類 |
| US8796314B2 (en) | 2009-01-30 | 2014-08-05 | Millennium Pharmaceuticals, Inc. | Heteroaryls and uses thereof |
| JP2012516329A (ja) * | 2009-01-30 | 2012-07-19 | ミレニアム ファーマシューティカルズ， インコーポレイテッド | Ｐｉ３ｋ阻害剤としてのヘテロアリールおよびその使用 |
| US9090601B2 (en) * | 2009-01-30 | 2015-07-28 | Millennium Pharmaceuticals, Inc. | Thiazole derivatives |
| US9062038B2 (en) | 2010-08-11 | 2015-06-23 | Millennium Pharmaceuticals, Inc. | Heteroaryls and uses thereof |
| EP2603214A4 (en) | 2010-08-11 | 2013-12-18 | Millennium Pharm Inc | HETEROARYLE AND USES THEREOF |
| US8859768B2 (en) | 2010-08-11 | 2014-10-14 | Millennium Pharmaceuticals, Inc. | Heteroaryls and uses thereof |
| MX2013004003A (es) | 2010-10-13 | 2013-10-01 | Millenium Pharmaceuticals Inc | Heteroarilos y usos de los mismos. |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4322429A (en) * | 1980-09-16 | 1982-03-30 | Eli Lilly And Company | Isoxazolylbenzamides as insecticides |
| US4818270A (en) * | 1986-08-28 | 1989-04-04 | Monsanto Company | 2-(Heteroamino)-4,5-substituted-oxazole/thiazole compounds as herbicide antidotes, compositions and use |
| US6194447B1 (en) * | 1998-07-02 | 2001-02-27 | Neurosearch A/S | Bis (benzimidazole) derivatives serving as potassium blocking agents |
| CA2416527C (en) | 2000-08-10 | 2009-12-22 | Pharmacia Italia S.P.A. | Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| GB0102687D0 (en) | 2001-02-02 | 2001-03-21 | Pharmacia & Upjohn Spa | Oxazolyl-pyrazole derivatives active as kinase inhibitors,process for their preparation and pharmaceutical compositions comprising them |
| WO2003070283A2 (en) | 2002-02-22 | 2003-08-28 | Klaus Strebhardt | Agent for inhibiting development or progress of proliferative diseases and especially cancer diseases and pharmaceutical composition containing said agent |
| NZ535232A (en) | 2002-02-28 | 2007-05-31 | Univ Temple | Amino-substituted (E)-2,6-dialkoxystyryl 4-substituted benzylsulfones for treating proliferative disorders |
| JP2003321460A (ja) * | 2002-02-28 | 2003-11-11 | Takeda Chem Ind Ltd | アゾール化合物 |
| US7183276B2 (en) * | 2002-02-28 | 2007-02-27 | Takeda Pharmaceutical Company Limited | Azole compounds |
| RS95404A (sr) | 2002-05-03 | 2006-10-27 | Schering Aktiengesellschaft | Tiazolidinoni i njihova primena kao inhibitora polo like kinaze |
| US6906186B1 (en) | 2002-07-30 | 2005-06-14 | Isis Pharmaceuticals, Inc. | Antisense modulation of polo-like kinase expression |
| MXPA05001544A (es) | 2002-08-08 | 2005-04-19 | Smithkline Beecham Corp | Compuestos de tiofeno. |
| WO2004046317A2 (en) | 2002-11-14 | 2004-06-03 | Massachusetts Institue Of Technology | Products and processes for modulating peptide-peptide binding domain interactions |
| WO2004043936A1 (ja) | 2002-11-14 | 2004-05-27 | Kyowa Hakko Kogyo Co., Ltd. | Ｐｌｋ阻害剤 |
| JP3837670B2 (ja) | 2002-12-12 | 2006-10-25 | 富士通株式会社 | データ中継装置、連想メモリデバイス、および連想メモリデバイス利用情報検索方法 |
| GB0302220D0 (en) | 2003-01-30 | 2003-03-05 | Cyclacel Ltd | Use |
| ES2325440T3 (es) | 2003-02-20 | 2009-09-04 | Smithkline Beecham Corporation | Compuestos de pirimidina. |
| US7462614B2 (en) | 2003-04-01 | 2008-12-09 | Smithkline Beecham Corporation | Imidazotriazine compounds |
| DK1641780T3 (da) | 2003-06-24 | 2009-02-02 | Pfizer Prod Inc | Fremgangsmåder til fremstilling af 1-[(benzimidazol-1yl)quinolin-8-yl]-piperidin-4-ylamin-derivater |
| WO2005019193A2 (en) | 2003-08-20 | 2005-03-03 | Smithkline Beecham Corporation | Phenylurea derivatives useful in the treatment of conditions mediated by polo-like kinases (plk) |
| BRPI0415759A (pt) | 2003-10-21 | 2006-12-19 | Cyclacel Ltd | compostos de pirimidin-4-il-3,4-tiona e uso dos mesmos na terapia |
| DE10351744A1 (de) | 2003-10-31 | 2005-06-16 | Schering Ag | Thiazolidinone, deren Herstellung und Verwendung als Arzneimittel |
| JP2007519720A (ja) | 2004-01-28 | 2007-07-19 | スミスクライン ビーチャム コーポレーション | チアゾール化合物 |
-
2007
- 2007-02-07 US US11/703,306 patent/US7504513B2/en not_active Expired - Fee Related
- 2007-02-19 CA CA002642921A patent/CA2642921A1/en not_active Abandoned
- 2007-02-19 CN CNA2007800068055A patent/CN101415704A/zh active Pending
- 2007-02-19 WO PCT/EP2007/051541 patent/WO2007096315A1/en not_active Ceased
- 2007-02-19 BR BRPI0710473-1A patent/BRPI0710473A2/pt not_active IP Right Cessation
- 2007-02-19 JP JP2008555763A patent/JP2009528284A/ja active Pending
- 2007-02-19 AU AU2007217575A patent/AU2007217575A1/en not_active Abandoned
- 2007-02-19 EP EP07712233A patent/EP1991543A1/en not_active Withdrawn
- 2007-02-19 RU RU2008138163/04A patent/RU2008138163A/ru not_active Application Discontinuation
- 2007-02-19 MX MX2008010884A patent/MX2008010884A/es not_active Application Discontinuation
- 2007-02-19 KR KR1020087021067A patent/KR101060539B1/ko not_active Expired - Fee Related
- 2007-02-23 AR ARP070100768A patent/AR059621A1/es unknown
- 2007-02-26 TW TW096106341A patent/TW200745097A/zh unknown
-
2008
- 2008-08-14 IL IL193481A patent/IL193481A0/en unknown
- 2008-08-14 CR CR10206A patent/CR10206A/es not_active Application Discontinuation
- 2008-08-15 ZA ZA200807074A patent/ZA200807074B/xx unknown
- 2008-08-26 EC EC2008008700A patent/ECSP088700A/es unknown
- 2008-08-28 NO NO20083708A patent/NO20083708L/no not_active Application Discontinuation
- 2008-09-04 MA MA31208A patent/MA30260B1/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA200807074B (en) | 2009-10-28 |
| US7504513B2 (en) | 2009-03-17 |
| MX2008010884A (es) | 2008-09-03 |
| NO20083708L (no) | 2008-09-23 |
| BRPI0710473A2 (pt) | 2011-08-16 |
| IL193481A0 (en) | 2009-05-04 |
| WO2007096315A1 (en) | 2007-08-30 |
| RU2008138163A (ru) | 2010-04-10 |
| TW200745097A (en) | 2007-12-16 |
| JP2009528284A (ja) | 2009-08-06 |
| US20070203210A1 (en) | 2007-08-30 |
| KR101060539B1 (ko) | 2011-08-30 |
| MA30260B1 (fr) | 2009-03-02 |
| AU2007217575A1 (en) | 2007-08-30 |
| CR10206A (es) | 2008-09-22 |
| ECSP088700A (es) | 2008-09-29 |
| KR20080090550A (ko) | 2008-10-08 |
| CA2642921A1 (en) | 2007-08-30 |
| CN101415704A (zh) | 2009-04-22 |
| EP1991543A1 (en) | 2008-11-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR116993A2 (es) | Compuestos heterociclos bicíclicos y sus usos en terapia | |
| AR080314A1 (es) | Derivado de 1,3,4,8-tetrahidro-2h-pirido (1,2-a) pirazina y su uso como inhibidor de la hiv integrasa | |
| AR054560A1 (es) | Espiropiperidina como inhibidores de beta-secretasa para el tratamiento de la enfermedad de alzheimer | |
| CO6170361A2 (es) | Composiciones y metodos para modular receptores de c-kit y pdgfr | |
| AR080187A1 (es) | Derivados pirazolicos condensados con heterociclos nitrogenados utiles en el tratamiento de enfermedades inflamatorias, inmunitarias y/o trastornos mieloploliferativos y composiciones farmaceuticas que los contienen. | |
| AR067478A1 (es) | Compuestos derivados de morfolina pirimidina | |
| CO6160296A2 (es) | Derivados de acido benzoazepin-oxi-acetico como agonistas de receptores activados por proliferador de peroxisona delta usados para incrementar la lipoproteina de alta densidad-colesterol-colesterol reducir la lipoproteina de baja densidad-colesterol | |
| AR062677A1 (es) | Derivados de biaril-sulfonamida, procesos de produccion y composiciones farmaceuticas que los comprenden | |
| AR061548A1 (es) | 3-aminopirrolidino-4-lactamas sustituidas como inhibidoras de dipeptidilpeptidasa iv (dpp-iv), composiciones farmaceuticas que las comprenden y el uso de las mismas en el tratamiento de la diabetes ii. | |
| AR082696A1 (es) | Derivados heterociclicos nitrogenados de 1,2,4-oxadiazol, composiciones farmaceuticas que los contienen y uso de los mismos en el tratamiento de enfermedades cardiovasculares e inflamatorias, entre otras | |
| EA200970493A1 (ru) | Макроциклические ингибиторы вируса гепатита с | |
| AR079205A1 (es) | Morfolinotiazoles como moduladores alostericos positivos alfa 7 | |
| CO6251271A2 (es) | Derivados de pirimidina trisustituida para el tratamiento de enfermedades proliferativas | |
| AR045388A1 (es) | Inhibidores del c-kit imidazopiridinicos n3-sustituidos | |
| AR076579A1 (es) | Espironucleosidos uracilicos oxetanicos, composiciones farmaceuticas que los contienen y uso de los mismos como inhibidores del virus de la hepatitis c (vhc). | |
| AR082109A1 (es) | Derivados de bipiridilo | |
| AR077292A1 (es) | Derivados de piperazin - quinolin sulfonamidas y composiciones farmaceuticas | |
| ES2570127T3 (es) | Compuestos y composiciones como inhibidores de la proteína quinasa | |
| AR081058A1 (es) | Derivados de arilmetoxi isoindolina, composiciones que los comprenden y su uso en el tratamiento del cancer. | |
| AR041260A1 (es) | Piperazinas sustituidas por heterociclos para el tratamiento de la esquizofrenia | |
| AR074504A1 (es) | Nucleotidos uracil ciclopropilicos | |
| AR088828A1 (es) | DERIVADOS DE CICLOHEXILAMINA QUE TIENEN ACTIVIDAD COMO AGONISTAS ADRENERGICOS b2 Y COMO ANTAGONISTAS MUSCARINICOS M3 | |
| AR075951A1 (es) | Dihidropiridin sulfonamidas y dihidropiridin sulfamidas como inhibidores de mek | |
| CO2020001326A2 (es) | Nuevos compuestos heterocíclicos como inhibidores de cdk8/19 | |
| AR082619A1 (es) | Inhibidores del virus de la hepatitis c |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |